PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $188,000 | -13.0% | 65,242 | -8.1% | 0.01% | 0.0% |
| Q4 2021 | $216,000 | -91.2% | 71,012 | +70.9% | 0.01% | -86.2% |
| Q2 2018 | $2,458,000 | +4.4% | 41,560 | +20.1% | 0.06% | +1.8% |
| Q1 2018 | $2,355,000 | +298.5% | 34,613 | +479.1% | 0.06% | +307.1% |
| Q4 2017 | $591,000 | -21.1% | 5,977 | -46.5% | 0.01% | -17.6% |
| Q3 2016 | $749,000 | -21.9% | 11,177 | +175.3% | 0.02% | -10.5% |
| Q1 2015 | $959,000 | +24.9% | 4,060 | 0.0% | 0.02% | +35.7% |
| Q4 2014 | $768,000 | -35.4% | 4,060 | -18.5% | 0.01% | -33.3% |
| Q3 2014 | $1,188,000 | -31.0% | 4,980 | -80.9% | 0.02% | -25.0% |
| Q2 2014 | $1,722,000 | +38.8% | 26,097 | +119.0% | 0.03% | +40.0% |
| Q1 2014 | $1,241,000 | – | 11,917 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |